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Abstract
Purpose 18F-FDG PET is used to investigate the metabolic
activity of neural tissue. MRI is used to visualize morpholog-
ical changes, but the relationship between intramedullary sig-
nal changes and clinical outcome remains controversial. The
present study was designed to evaluate the use of 3-D
MRI/18F-FDG PET fusion imaging for defining intramedul-
lary signal changes onMRI scans and local glucose metabolic
rate measured on 18F-FDG PET scans in relation to clinical
outcome and prognosis.
Methods We studied 24 patients undergoing decompressive
surgery for cervical compressive myelopathy. All patients
underwent 3-D MRI and 18F-FDG PET before surgery.
Quantitative analysis of intramedullary signal changes on
MRI scans included calculation of the signal intensity ratio
(SIR) as the ratio between the increased lesional signal
intensity and the signal intensity at the level of the C7/T1
disc. Using an Advantage workstation, the same slices of
cervical 3-D MRI and 18F-FDG PET images were fused. On
the fused images, the maximal count of the lesion was
adopted as the standardized uptake value (SUVmax). In a
similar manner to SIR, the SUV ratio (SUVR) was also
calculated. Neurological assessment was conducted using
the Japanese Orthopedic Association (JOA) scoring system
for cervical myelopathy.
Results The SIR on T1-weighted (T1-W) images, but not
SIR on T2-W images, was significantly correlated with
preoperative JOA score and postoperative neurological
improvement. Lesion SUVmax was significantly corre-
lated with SIR on T1-W images, but not with SIR on
T2-W images, and also with postoperative neurologi-
cal outcome. The SUVR correlated better than SIR on
T1-W images and lesion SUVmax with neurological
improvement. Longer symptom duration was correlat-
ed negatively with SIR on T1-W images, positively
with SIR on T2-W images, and negatively with
SUVmax.
Conclusion Our results suggest that low-intensity signal on
T1-W images, but not on T2-W images, is correlated with a
poor postoperative neurological outcome. SUVmax of
lesions showing increased signal intensity and SUVR mea-
sured on fusion MRI/PET scans are more sensitive parame-
ters for predicting clinical outcome than signal intensity on
the MRI scan.
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Introduction
It is important to assess spinal cord function in
patients with cervical compressive myelopathy consid-
ered suitable for neurosurgical treatment. The majority
of conventional tests focus on evaluation of neural
conductivity across the damaged spinal cord [1], or
morphological and pathological changes at the com-
pressed cord that can be identified on MRI. MRI is
valuable before surgical decompression because it vis-
ualizes not only the magnitude of the spinal cord
compression but also the intramedullary signal intensi-
ty. Many authors have reported high intramedullary
signal intensity on T2-weighted (T2-W) MR images
in patients with compressive spondylotic lesions of
the cervical spinal cord [2–5]. This abnormality in
intramedullary signal intensity is considered to repre-
sent myelomalacia or cord gliosis secondary to long-
standing compression of the spinal cord [4]. Therefore,
the presence of high intramedullary signal intensity in
patients with compressive myelopathy indicates the
existence of a compressive spinal cord lesion of long
duration. However, the prognostic capacity of these
imaging parameters remains controversial, especially
with regard to the change in signal intensity of the
spinal cord on T2-W MR images. Increased signal
intensity on T2-W MR images of the spinal cord and
decreased signal intensity on T1-weighted (T1-W)
images of the spinal cord are considered to predict a
poor neurological outcome. The cause of controversy
is thought to be the lack of quantitative assessment of
these changes in signal intensity.
18F-FDG PET has been used to investigate the metabolic
activity of neural tissue including the spinal cord [6]. We used
high-resolution 18F-FDG PET to visualize the cervical spinal
cord and quantify its metabolic activity [7], and have also
found that patients with cervical myelopathy have a variable
rate of glucose utilization in the whole cervical spinal cord [8],
and that impaired glucose metabolic activity in these patients
correlates closely with the severity of preoperative neurolog-
ical dysfunction [9]. Recent studies by another group have
demonstrated that regional changes in spinal cord 18F-
FDG uptake have prognostic significance in cervical
myelopathy [10, 11]. Thus, it is possible that the com-
bination of MRI and 18F-FDG PET could uncover new
features of cervical compressive myelopathy with re-
spect to prognosis.
The present study was designed to evaluate the utility of
3-D MRI/18F-FDG PET fusion imaging in the detection of
spinal cord lesions and to define intramedullary signal
changes on MRI and local glucose metabolic rate measured




Between June 2008 and May 2011, 139 patients, 94 with
cervical spondylotic myelopathy (CSM) and 45 with an
ossified posterior longitudinal ligament (OPLL), underwent
decompressive cervical spine surgery at our university med-
ical centre. Of these 139 patients, 24 were enrolled in this
study on the basis on the following criteria: (1) confirmation
of monosegmental compression of the cervical spinal cord at
the level of the spinal intervertebral disc in each patient (C2/
3 in one patient, C3/4 in eight patients, C4/5 in seven
patients, C5/6 in six patients, C6/7 in two patients) before
surgery based on the presence of high intramedullary signal
intensity on sagittal T2-W MR images obtained with a 1.5-T
Signa system (General Electric, Milwaukee, WI); (2) lack of
other lesions in the cervical vertebral column or spinal cord
such as developmentally narrow canal detected on the plain
radiograph, multisegmental lesions on MRI, or a history of
traumatic cervical spinal cord injury; (3) lack of comorbid-
ities such as diabetes mellitus; (4) providing signed consent.
The patients comprised 17 men and 7 women with a
mean age at surgery of 64.5 years (range 34 to 86 years),
and of these 24 patients 20 had CSM and 4 had OPLL. The
mean duration of neurological symptoms was 14.8 months
(range 3–36 months). Patients with a high intramedullary
signal intensity underwent both 3-D MRI for a second time
and 18F-FDG PET for this clinical study during the week
before surgery. Anterior decompression with autogenous
iliac bone grafting was performed in 20 patients, and en
bloc open-door laminoplasty was performed in 4 patients.
All examinations including the 18F-FDG PET study strictly
followed the Ethics Review Committee Guidelines of Fukui
University and written informed consent was obtained from
all patients. The 18F-FDG PET study was undertaken as an
Advanced Medical Technology Development Project at
Fukui University.
Neurological assessment was conducted in accordance
with the Japanese Orthopedic Association (JOA) scoring
system for cervical myelopathy. The mean period of neuro-
logical follow-up was 14.1 months (range 6–36 months).
The rate of neurological improvement was calculated by the
following equation: (postoperative JOA score−preoperative
JOA score)/(17−preoperative JOA score)×100. An im-
provement of 100 % was the best possible postoperative
recovery [12].
High-resolution MRI
MRI examination of the spinal cord for the MRI/PET fusion
study was performed preoperatively using 3.0-T Signa sys-
tem (General Electric). T1-W and T2-W sagittal images of
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the spinal cord were obtained using a fast spin echo se-
quence. An additional 3-D fast spoiled gradient echo se-
quence was used for T1-W imaging with contiguous thin
sections of 0.4 mm covering the entire cervical spine region.
Quantitative analysis was conducted as described previously
[13]. T2-W midsagittal images of the cervical spinal cord
with increased signal intensity were obtained first because
small changes in signal intensity on T1-W images are diffi-
cult to visualize, and the region of interest (ROI) is only
0.05 cm2. The same spinal cord lesions identified on T1-W
and T2-W images were viewed on a Hurry PACS (Cosmo
Medical Systems Co., Osaka, Japan) with ROIs of 0.05 cm2.
T2- and T1-W midsagittal MR images of the cervical spinal
cord with normal signal intensity (level of the C7/T1 disc)
with ROI 0.3 cm2 were also obtained. The signal intensity
was measured on the PACS client viewer, and the differ-
ences in signal intensity in the cord were qualitatively
assessed on both T1-W and T2-W images. In quantitative
analysis of the differences in signal intensity, the signal
intensity ratios (SIR) on both T1-W and T2-W images were
calculated as the ratio between the increased lesional signal
intensity in the midsagittal plane (ROI 0.05 cm2) and the
signal intensity in the midsagittal plane at the level of the
C7/T1 disc (ROI 0.3 cm2).
18F-FDG PET study
The 18F-FDG PET examination of the cervical spinal cord
was performed preoperatively using a GE Advance system
(General Electric). This system allows simultaneous acqui-
sition of 35 transverse slices with an interslice spacing of
4.25 mm with septa (2-D mode). The PET camera was
cross-calibrated using a cylindrical phantom filled with
18F− solution. Images were reconstructed to a full-width at
half-maximum of 4.2 mm in both transaxial and axial direc-
tions. The field of view and pixel size of the reconstructed
images were 256 mm and 2 mm, respectively. Subjects were
studied after fasting for at least 4 h. Transmission scans were
obtained over 10 min using a standard 68Ge/68Ga rod source
for attenuation correction of the emission images. 18F-FDG
was injected at a dose of 185 MBq into an antecubital vein
over 10 s. Static scans were then obtained 50 min after
injection over 10 min.
MRI/18F-FDG PET image fusion and assessment
Using an Advantage workstation (GE Healthcare), the
same slices of the cervical 3-D MRI scan obtained
using a 3.0-T Signa system and the 18F-FDG PET
images were fused automatically and manually by iden-
tifying the cerebellar tonsil and laryngopharynx as the
corresponding landmarks. To determine the glucose met-
abolic rate of the cervical spinal cord, round ROIs each
4 mm in diameter were placed on the spinal cord on the
same lesions identified on the sagittal fused MR images.
The reconstructed tissue activity images were converted
to standardized uptake value (SUV) images corrected
for the injected dose and patient body weight using
the following equation: SUV0 tissue activity in kilobec-
querels per millilitre/(injected 18F-FDG dose in mega-
becquerels/body weight in kilograms).
The ROI counts were determined in lesions showing
increased signal intensity in the sagittal plane and at the
level of the C7/T1 disc. For the same lesion, the maximal
ROI count (SUVmax) was then adopted as the tissue radio-
activity to reduce the partial volume effect [14, 15]. Further-
more, at the level of the C7/T1 disc, the mean ROI count
(SUVmean) was adopted to reduce the individual differences.
In a similar manner to SIR, the SUV ratios (SUVR) were
calculated as the ratios between the SUVmax of the cervical
spinal cord lesions showing increased signal intensity on
fused MR images in the sagittal plane (diameter 4 mm) and
the SUVmean of the normal cervical spinal cord at the level
of the C7/T1 disc (diameter 4 mm).
Data analysis
Pearson partial correlation analysis was used to examine the
relationship among neurological scores, SIR, SUVmax,
SUVR and duration of the disease. All statistical analyses
were conducted using the Statistical Package for Social
Sciences (version 15.0; SPSS, Chicago, IL).
Results
Table 1 summarizes the demographic data of the patients.
Correlation analysis showed no significant correlation be-
tween age and SUVmax (R00.127). The SUVmax for the
lesions showing increased signal intensity in the sagittal
plane on T2-W images showed various patterns (1.60–
2.89). Examples are shown in Figs. 1 and 2. Figure 1 (pa-
tient 22) shows a significant increase in 18F-FDG uptake
(SUVmax 2.50, SUVR 1.84) at the level of the lesion (SIR on
T1-W image 1.29, SIR on T2-W image 1.55). The rate of
neurological improvement was considered good (75.0 %) at
follow-up. On the other hand, Fig. 2 (patient 16) demon-
strates no increase in 18F-FDG uptake (SUVmax 1.60, SUVR
0.87) at the level of the lesion (SIR on T1-W image 0.99,
SIR on T2-W image 1.48). The rate of neurological im-
provement at follow-up was poor (28.6 %).
Relationship between SIR on MRI and clinical outcome
Figure 3 shows the relationship between SIR on T1-W
images and T2-W images and neurological scores. The











































































































































































































































































































































































































































































































































































































































































































































































































Eur J Nucl Med Mol Imaging (2012) 39:1528–1537 1531
SIR on T1-W images was correlated significantly with the
preoperative JOA score (R00.430; p<0.05; Fig. 3a) and
postoperative neurological improvement (R00.617; p<
0.01; Fig. 3c). However, there were no significant correla-
tion between the intramedullary signal intensity on T2-W
images and the preoperative JOA score (R0−0.174; Fig. 3b)
or postoperative neurological improvement (R0−0.256;
Fig. 3d).
Clinical significance of SUVmax for lesions showing
increased signal intensity
Figure 4 shows the relationship between SUVmax for
lesions showing increased signal intensity in the sagittal
plane and SIR on T1-W and T2-W images as well as
neurological scores. SUVmax for the lesions was corre-
lated significantly with SIR on T1-W images (R00.718,
p<0.001; Fig. 4a) but not on T2-W images (R0−0.237;
Fig. 4b). Furthermore, SUVmax was correlated with
postoperative neurological improvement (R00.636, p<
0.001; Fig. 4d) but not with the preoperative JOA score
(R00.251; Fig. 4c).
Clinical significance of the SUV ratio (SUVR)
Figure 5 shows the relationship between SUVR and SIR on
T1-W images and T2 -W images as well as neurological score.
SUVR was correlated significantly with SIR on T1-W images
(R00.704, p<0.001; Fig. 5a) but not on T2-W images (R0
−0.210; Fig. 5b). Furthermore, SUVmax was correlated signif-
icantly with postoperative neurological improvement, and the
correlation coefficient was much higher than that for SUVmax
for lesions showing increased signal intensity on the sagittal
plane (R00.837, p<0.001; Fig. 5d), but not with preoperative
JOA score (R00.293; Fig. 5c).
Effect of disease duration on SIR and SUVmax for lesions
showing increased signal intensity
SIR on T1-W images and T2-W images and SUVmax for
lesions showing increased signal intensity were correlated
with the duration of symptoms of myelopathy. A longer
duration of symptoms was associated with a lower SIR on
T1-W images (R0−0.616, p<0.01), but with a higher SIR
on T2-W images (R00.421, p<0.05). Furthermore, SUVmax
Fig. 1 Patient 22. An 80-year-old woman with cervical spondylotic
myelopathy was treated surgically and showed a neurological improve-
ment rate of 75.0 % at follow-up. a Midsagittal T1-W MR image. b
Midsagittal T2-W MR image. c MRI/PET fusion image. d T1-W MR
image for calculation of SIR as the ratio of the signal intensity in the
midsagittal area of increased signal intensity (small circle) to the signal
intensity in the midsagittal area of normal signal intensity at the level of
the C7/T1 disc (larger circle), e T2-W image for calculation of SIR in a
similar manner. f Sagittal 18F-FDG PET image. g Sagittal MRI/PET
fusion image demonstrates a focal increase in 18F-FDG uptake at the
level of a lesion showing increased signal intensity. SUVR is calculat-
ed as the ratio between the SUVmax of the lesion (circle diameter
4 mm) and the SUVmean of the normal cord at the level of the C7/
T1 disc (circle diameter 4 mm)
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Fig. 2 Patient 16. A 62-year-old man with cervical spondylotic mye-
lopathy was treated surgically and showed a poor neurological im-
provement rate of 28.6 % at follow-up. aMidsagittal T1-W MR image.
bMidsagittal T2-W MR image. cMRI/PET fusion image. d T1-WMR
image for calculation of SIR as the ratio of the signal intensity in the
midsagittal area of increased signal intensity (small circle) to the signal
intensity in the midsagittal area of normal signal intensity at the level of
the C7/T1 disc (larger circle), e T2-W image for calculation of SIR in a
similar manner. f Sagittal 18F-FDG PET image. g Sagittal MRI/PET
fusion image demonstrates inconspicuous 18F-FDG uptake at the level
of a lesion showing increased signal intensity. SUVR is calculated as
the ratio between the SUVmax of the lesion (circle diameter 4 mm) and
the SUVmean of the normal cord at the level of the C7/T1 disc (circle
diameter 4 mm)
Fig. 3 Relationship between
SIR and neurological scores.
Preoperative JOA scores (a, b
pre JOA) and postoperative
neurological improvement (c, d
JOA improvement rate) are
significantly correlated with
SIR on T1-W images (a, c) but
not on T2-W images (b, d). The
values of R in blue indicate
weak correlations, the values in
black indicate no correlation
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was correlated negatively with duration of symptoms (R0
−0.453, p<0.05).
Discussion
Several groups have investigated the factors involved in the
prognosis in patients with CSM and OPLL [5, 12, 16–18].
Recognition of the functional capacity and functional nor-
malization of the chronically damaged spinal cord are im-
portant clinical issues. It is also important to know those
factors that determine neurological improvement after sur-
gery. Age at surgery [16], duration of neurological symp-
toms [5, 16, 17, 19–21], and existence of signal changes on
preoperative MRI [2–4, 22, 23] have been considered key
predictors of surgical outcome. These factors could also
Fig. 4 Relationship between
SUV for the lesions and signal
intensity on MRI/PET fusion
images and SIR and
neurological scores. Lesional
SUVmax values are strongly
correlated with SIR on T1-W
images (a) but not on T2-W
images (b). SUVmax values are
not significantly correlated with
preoperative JOA scores (c pre
JOA), but are significantly cor-
related with postoperative neu-
rological improvement (d JOA
improvement rate). The value
of R in red indicates a strong
correlation, the value in blue
indicates a weak correlation, the
values in black indicate no
correlation
Fig. 5 Relationship between
SUVR on MRI/PET fusion
images and SIR and
neurological scores. SUVR was
strongly correlated with SIR on
T1-W images (a) but not on T2-
W images (b). SUVR was not
significantly correlated with
preoperative JOA scores (c pre
JOA), but was significantly
correlated with postoperative
neurological improvement (d
JOA improvement rate). The
values of R in red indicate a
strong correlation, the values in
black indicate no correlation
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have had a significant impact on the surgical outcome in the
patients in the present study as well, although we focused on
changes in the signal intensity on MRI and local glucose
metabolism in monosegmental spinal cord lesions on PET
using high-resolution MRI/PET fusion imaging.
While MRI provides the highest specificity in the assess-
ment of morphological changes and the intramedullary state of
the spinal cord, it is almost impossible to estimate the potential
recovery of the spinal cord on preoperative MRI without
quantitative analysis. Furthermore, the signal intensities on
MRI scans are irregular because different sequence parameters
are set for each individual patient. On the other hand, 18F-FDG
PETallows visualization of the metabolic activity of the spinal
cord neural tissue under the same conditions in each scan, and
this parameter correlates closely with neurological prognosis.
We have previously quantified glucose utilization in the cervi-
cal spinal cord of patients with myelopathy [8]. Furthermore,
Kamoto et al. [7] reported that the normal metabolic rate of
glucose utilization in the cervical spinal cord (SUV) in healthy
Japanese subjects (aged 40–70 years) was 1.93±0.23, although
the value was found to be 2.12±0.48 by Nakamoto et al. [24]
and 1.84±0.23 by Floeth et al. [11]. In another study, we found
that patients with mild to moderate myelopathy have a high
SUVof the entire cervical spinal cord, while those with marked
and profound tetraparesis had a low SUV [9]. Thus, a high
SUV seems to reflect hyperactive neuronal activity within the
spinal cord. In our latest study, patients with poor neurological
improvement rate were found to have low preoperative SUV
and a low level of postoperative neurological improvement
[25]. Unfortunately, our results showed that preoperative SUV
was not significantly different among patients with increased
signal intensity on MRI. In reconsidering the above findings,
we believe that the major problems in such analysis are (1) the
lack of clear grouping of T1-Wand T2-W images on MRI, (2)
the use of SUV values that represented the average of the entire
cervical spinal cord, rather than local SUV, as applied in the
present study, and (3) the difficulty in identifying lesions
showing an increase in signal intensity by PET.
The MRI/PET fused images were constructed in the present
study based on preliminary studies and our previous experi-
ence. The 3-T MRI scanner has an in-plane resolution capa-
bility of 400 μm and any slice can be shown in 3-D byMRI at
3 T—a feature hitherto unavailable with the 1.5-T MRI sys-
tem. The combination of the same slice imaged with the two
highest-end modalities in near real-time on simultaneous scans
has enabled us to image metabolic function with detectable
accuracy at the level of the cervical spinal cord. In this study,
we were able to assess accurately and in detail the metabolic
activity of lesions showing increased signal intensity. Our
results showed that 18F-FDG PET is more suitable and sensi-
tive for the detection of changes in low signal intensity on T1-
W images on MRI/PET fusion imaging. Our results also
suggested that SUVmax for lesions showing increased signal
intensity correlates with SIR on T1-W images and postopera-
tive neurological outcome, but not with SIR on T2-W images.
Additionally, the SUVR predicted neurological improvement
more sensitively than SIR on T1-W images or SUVmax in
lesions showing increased signal intensity. Floeth et al. [10]
found a significant decrease in 18F-FDG uptake in the area of
the lower cervical cord in patients with myelopathy than in the
control group. This could be the reason that made SUVR a
more sensitive predictor than SUVmax in lesions showing
increased signal intensity.
A high signal intensity on T2-WMR images indicates local
pathological changes in the spinal cord, and patients with
compressive myelopathy with high signal intensity on T2-W
MR images usually have a poorer prognosis even after surgi-
cal intervention [4, 22]. Recent studies have indicated that
qualitative or semiquantitative analysis of MR images is a
simple and easy technique in the clinical setting [13, 26–29].
In contrast, there is no significant correlation between high
signal intensity on T2-WMR images and postoperative prog-
nosis, and statistical analysis has also failed to confirm this
correlation [5, 23, 30]. The present quantitative study based on
MRI/PET fusion images also showed no correlation with SIR
on T2-W images, while SIR on T1-W images was correlated
with preoperative JOA score and postoperative neurological
improvement. High signal intensity is observed on T2-WMR
images in patients with early stage myelomalacia. Some
patients at an intermediate stage display a variable degree of
cystic necrosis of the central grey matter, which is better
visualized on T2-WMR images. Finally, central cystic degen-
eration, syrinx formation and atrophy are the main features of
late-stage myelomalacia [31–33]. On the other hand, several
groups have confirmed that low signal intensity on preopera-
tive T1-W MR images is a predictor of a poor prognosis [23,
30, 34]. Based on the results reported in the literature, high
intensity signal on T2-W images at early stages of compres-
sive myelopathy are indicative of oedema and gliosis (which
may be reversible), whereas low intensity signal on T1-W
images could reflect myelomalacia and necrosis (which are
considered irreversible). Decompression of the spinal cord by
surgery can restore blood circulation in the spinal cord, reduce
swelling, and enhance regeneration of nerve fibres, thus re-
ducing or normalizing the high signal intensity in the intra-
medullary region. In the late stage, necrosis and syrinx
become irreversible, making surgery ineffective.
Changes in 18F-FDG uptake at the site of the compressed
spinal cord seem to reflect its neuronal activity at different
stages of the pathophysiological course of myelopathy. Spinal
cord autopsy findings in patients with late-stage cervical my-
elopathy include demyelination, white matter axonal loss and
grey matter neuronal loss [35, 36]. In contrast, Yamamoto et
al. [37] found the presence of highly active neurogenic pro-
genitor cells in the grey matter in the adult rat spinal cord, and
that these cells could differentiate into neurons and glial cells
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following mechanical stimulation. In the twy/twymouse mod-
el (a model of human OPLL) our group found altered immu-
noreactivity to neurotrophins in the compressed spinal cord.
The early stages of cord compression were associated with
increased immunoreactivity of brain-derived neurotropic fac-
tor and neurotrophin-3 in neurons and astroglial cells in the
grey matter, which may explain the increased glucose metab-
olism [38]. In the early stages, the process is still reversible
and a good clinical outcome after surgical intervention is
expected. Long-term compression, however, leads to atrophy
and necrosis of the anterior grey horn cells and the loss of
glucose-consuming neurons and glia cells, resulting in de-
creased 18F-FDG uptake in the spinal cord during the late
stages. On the other hand, Esik et al. [39] have shown in-
creased 18F-FDG utilization in patients with myelitis, together
with an increased number of sodium channels along the
demyelinated segments of injured axons. The observed
changes in glucose metabolism on 18F-FDG PET in cervical
myelopathy could reflect neuronal plasticity in the com-
pressed spinal cord, neural activity, deterioration of synaptic
function, loss of neurons and neural tissue, changes in blood
flow, and the magnitude of mechanical compression. Al-
though the present study was limited by the small sample size,
we believe that glucose metabolism (SUV) measured onMRI/
PET fusion images is suitable for visualization of the meta-
bolic activity of neural tissue, and that 18F-FDG PET is a more
sensitive tool for assessment of the clinical outcome and
prognosis in patients with cervical compressive myelopathy.
Conclusion
This is the first study measuring regional glucose metabolism
in the affected spinal cord of patients with cervical compres-
sive myelopathy using MRI/PET fusion imaging. 3-D
MRI/18F-FDG PET fusion imaging is useful for mapping the
exact level of a cervical spinal cord lesion on the 18F-FDG
PET image. Assessment of neurological function by 18F-FDG
PET may be equal to or better than that assessed in term of
signal intensity on T1-W images. Preoperative glucose utili-
zation rate on 18F-FDG PET imaging seems suitable for
prediction of postoperative neurological outcome.
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